Aggregation

(redirected from platelet aggregation)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Aggregation

Process in corporate financial planning whereby the smaller investment proposals of each of the firm's operational units are aggregated and effectively treated as a whole.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

Aggregation

1. A composite report of all futures positions held by a single trader. Aggregations are used to ensure that reports are accurate and regulations are followed.

2. In corporate financial planning, the combination of several, small investments such that they are treated as one, large investment.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved
References in periodicals archive ?
Platelet counts were performed on each sample tube and the percentage platelet aggregation was calculated from the EDTA platelet count and sample tube platelet counts.
This offers critical cardiovascular protection, especially immediately after a meal, when platelet aggregation increases.
In the first group, which was given low dose aspirin (150mg) daily, platelet aggregation was inhibited significantly when assessed with both reagents, i.e., ADP as well as with collagen.
Platelet activation is connected with the release of granular contents such as ATP and [Ca.sup.2+] and surface P-selectin expression, which leads to strong platelet aggregation. In the present study, Ir-6 (10 and 20 [micro]M) inhibited the ATP-release reaction stimulated by 1 [micro]g/mL collagen (Figure 2(a)).
Despite these associations, there is still not enough evidence to define the etiology of SPS, which, due to its different forms of clinical presentation and inducibility characteristics of platelet aggregation, could have a multifactorial origin [9].
In this study, we found that sample anticoagulated with magnesium sulphate do not show platelet aggregation in peripheral blood smear when examined in light microscope.
GT can be distinguished from other platelet function disorders by a lack of platelet aggregation in response to all agonists and a normal response to ristocetin; unlike agonists which induce platelet aggregation (requiring functional GPIIb/IIIa), ristocetin induces platelet agglutination through a facilitation of VWF binding to glycoprotein Ib and therefore serves as a measure of VWF activity.
When 46 [micro]M or more galangin was added to PRP, significant inhibition was detected in the collagen-included platelet aggregation test group in a dose-dependent manner.
The first phase of the experiment proved that each of the radiation dose applied caused a significant decrease in platelet aggregation when compared to the nonirradiated control group, regardless of the agonist administered.
All the agonists used in the platelet aggregation assays (collagen from equine tendon, adenosine diphosphate (ADP), and ristocetin) were purchased from Helena Laboratories (Beaumont, Texas, USA).
In the control group with increasing age, platelet aggregation was noted to be increased in response to all agonists and their combinations.
Many studies have shown that disintegrins are capable of inhibiting platelet aggregation induced by collagen, adenosine diphosphate (ADP), arachidonic acid, ristocetin, and thrombin [16, 21]

Full browser ?